24 January 2022 | Dubai World Trade Centre, Dubai, UAE


Live, in-person

24 January 2022

Dubai World Trade Centre


CME accredited

24 January 2022
Bangkok Room, Dubai World Trade Centre



The track covered several developments in the field of haematology including the latest updates and recommendations in lymphoma and anemia. It also highlighted issues and challenges on quality management and aim to upgrade skills and knowledge of lab professionals on high sensitive flow cytometry

Key topics:

  • Quality Assurance
  • Application of CRISPR-Cas9 gene editing technology in the treatment of sickle cell anemia
  • Diagnostic challenges in detecting minimal residual disease by high-sensitive flow cytometry for B-ALL

Scientific Chairs:

  • Dr Chethan Belludi, Consultant Physician, HQ Medical Operations Division, Union71, SEHA, Abu Dhabi, UAE
  • Dr Aaron Han, Consultant Pathologist, Adjunct Professor, MBRU School of Medicine; Vice President, Emirates
    Pathology Society, Deputy International Commissioner for UAE, CAP; King's Hospital London,
    Dubai, UAE

Benefits of attending:

  • Review the updated recommendations in lymphoma workup
  • Analyse the latest in flow cytometry, a powerful took for assessing MRD
  • Evaluate quality management in haematology, with a focus on lean six sigma and how to manage overload